Mirae Asset Global ETFs Holdings’s KalVista Pharmaceuticals KALV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$260K Sell
22,964
-1,361
-6% -$15.4K ﹤0.01% 2153
2025
Q1
$281K Buy
24,325
+2,939
+14% +$34K ﹤0.01% 2139
2024
Q4
$181K Sell
21,386
-1,204
-5% -$10.2K ﹤0.01% 2435
2024
Q3
$263K Buy
22,590
+6,320
+39% +$73.6K ﹤0.01% 2228
2024
Q2
$192K Buy
+16,270
New +$192K ﹤0.01% 2273